CIK 0001635088 · Large accelerated filer
Roivant Sciences Ltd.
Sign in to watch- Ticker
- ROIV
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- Bermuda
- Entity type
- operating
- EIN
- 981173944
- Phone
- 441-295-5950
- Business address
- 7TH FLOOR, 50 BROADWAY, LONDON, United Kingdom, SW1H 0DB
- 4 Other disposition Director disposed of 3,282 shares (other)
- 4 Other disposition Director disposed of 1,661 shares (other)
- 4 Open-market sale 10% owner sold 1,775,749 shares at an average $12.65 ($22,456,210)
- 4 Shares withheld for taxes CFO gave up 2,340 shares (to pay taxes)
- 4 Shares withheld for taxes CFO gave up 1,235 shares (to pay taxes)
- 4 Planned sale President & Immunovant CEO sold 100,000 shares at $11.72 ($1,172,000)
- 4 Grant or award President and Vant Chair acquired 13,736,547 shares (grant or award)
- 4 Grant or award President & Immunovant CEO acquired 198,413 shares (grant or award)
- 4 Shares withheld for taxes CFO gave up 1,919 shares (to pay taxes)
- 3 Insider Initial Statement of Ownership
- 4 Planned sale President & Immunovant CEO sold 100,000 shares at $11.52 ($1,152,000)
- 4 Shares withheld for taxes Director gave up 115 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 241 shares (to pay taxes)
- 4 Grant or award Director acquired 1,609 shares (grant or award)
- 4 Shares withheld for taxes CFO gave up 1,653 shares (to pay taxes)
- 4 Other disposition Director disposed of 36,756,758 shares (other)
- 4 Other disposition Director disposed of 17,389,525 shares (other)
- 4 Other disposition Director by Deputization disposed of 36,756,758 shares (other)
- 4 Shares withheld for taxes CFO gave up 1,503 shares (to pay taxes)
- 4 Planned sale President & COO sold 100,000 shares at $11.45 ($1,145,000)
Page 7 of 26 · 511 filings